Literature DB >> 16076384

A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis.

Takao Saotome1, Yoshihiro Endo, Teiji Sasaki, Takahisa Tabata, Tetsu Hamamoto, Kazunori Fujino, Akira Andoh, Yutaka Eguchi, Tohru Tani, Yoshihide Fujiyama.   

Abstract

Severe acute pancreatitis is a clinical entity that can develop into multiple organ failure (MOF), and still has a poor prognosis. It is generally agreed that excessive humoral mediators such as pro-inflammatory cytokines play important roles in the pathogenesis of organ failure in patients with severe acute pancreatitis (SAP). Furthermore, it has been reported that continuous hemodiafiltration (CHDF) can remove the excess humoral mediators during the hypercytokinemic state of systemic inflammatory response syndrome (SIRS). We experienced a case of severe acute pancreatitis induced by alcohol abuse, on whom we performed cytokine apheresis. The patient was a 46 year-old male. He received 14 cytokine apheresis procedures, for about 4 hours in each session, using a CTR-001 direct hemoperfusion (DHP) cartridge. His serum levels of pro-inflammatory cytokines such as interleukin-6 (IL-6; 1649.1+/-667.1-1257.1+/-489.4 pg/mL, P=0.013) decreased significantly after the CTR-001 procedures. However tumor necrosis factor-alpha (TNF-alpha) (26.2+/-1.7-24.3+/-1.9 pg/mL, P=0.087), IL-1beta (6.1+/-2.9-3.49+/-1.1 pg/mL, P=0.477), IL-8 (192.5+/-33.4-229.5+/-51.8 pg/mL, P=0.754) and IL-10 (14.4+/-2.7-14.0+/-1.9 pg/mL, P=0.726) did not decrease statistically. Therefore, we conclude that in this case, cytokine apheresis using a CTR-001 cartridge was effective for reducing the pro-inflammatory cytokines during severe acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076384     DOI: 10.1111/j.1744-9987.2005.00299.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  3 in total

1.  Hemoperfusion plus continuous veno-venous hemofiltration in a pregnant woman with severe acute pancreatitis: a case report.

Authors:  Yi Tang; Ling Zhang; Ping Fu; Yan Kang; Fang Liu
Journal:  Int Urol Nephrol       Date:  2011-03-19       Impact factor: 2.370

2.  Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study.

Authors:  Y Kobe; S Oda; K Matsuda; M Nakamura; H Hirasawa
Journal:  Blood Purif       Date:  2007-11-23       Impact factor: 2.614

3.  High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study.

Authors:  Shiren Sun; Lijie He; Ming Bai; Hongbao Liu; Yangping Li; Li Li; Yan Yu; Meilan Shou; Rui Jing; Liyuan Zhao; Chen Huang; Hanmin Wang
Journal:  Ann Saudi Med       Date:  2015 Sep-Oct       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.